{
    "paper_id": "PMC7158830",
    "metadata": {
        "title": "Angiotensin receptor blockers and COVID-19",
        "authors": [
            {
                "first": "Juan",
                "middle": [
                    "M."
                ],
                "last": "Saavedra",
                "suffix": "",
                "email": "juan.saavedra@georgetown.edu",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The author has no conflict of interest to declare with respect to this manuscript.",
            "cite_spans": [],
            "section": "Declaration of Competing Interest",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Proposed protective mechanisms of ARB administration in COVID-19 patients.\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?",
            "authors": [
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Karakiulakis",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Roth",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir. Med.",
            "volume": "",
            "issn": "March (11)",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S2213-2600(20)30116-8"
                ]
            }
        },
        "BIBREF1": {
            "title": "Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19",
            "authors": [
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Diaz",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J. Travel Med.",
            "volume": "",
            "issn": "March (18)",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1093/jtm/taaa041"
                ]
            }
        },
        "BIBREF2": {
            "title": "Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Jia",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Shock",
            "volume": "46",
            "issn": "",
            "pages": "239-248",
            "other_ids": {
                "DOI": [
                    "10.1097/SHK.0000000000000633"
                ]
            }
        },
        "BIBREF3": {
            "title": "Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Gurwitz",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Drug Dev. Res.",
            "volume": "",
            "issn": "March (4)",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/ddr.21656"
                ]
            }
        },
        "BIBREF4": {
            "title": "Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and ebola",
            "authors": [
                {
                    "first": "D.S.",
                    "middle": [],
                    "last": "Fedson",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Am. Transl. Med.",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.21037/atm.2016.11.03"
                ]
            }
        },
        "BIBREF5": {
            "title": "The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "AlGhatrif",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Cingolani",
                    "suffix": ""
                },
                {
                    "first": "E.G.",
                    "middle": [],
                    "last": "Lakatta",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA Cardiol.",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jamacardio.2020.1329"
                ]
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}